Future research directions to improve fistula maturation and reduce access failure.
Future research directions to improve fistula maturation and reduce access failure.
复制标题
DOI:
10.1053/j.semvascsurg.2016.08.005
复制
发表时间:
2016-12
影响因子:
2.5
通讯作者:
Dardik A
中科院分区:
文献类型:
--
作者:
Hu H;Patel S;Hanisch JJ;Santana JM;Hashimoto T;Bai H;Kudze T;Foster TR;Guo J;Yatsula B;Tsui J;Dardik A
With the increasing prevalence of end stage renal disease there is a growing need for hemodialysis. Arteriovenous fistulae (AVF) are the preferred type of vascular access for hemodialysis but maturation and failure continue to present significant barriers to successful fistula use. AVF maturation integrates outward remodeling with vessel wall thickening in response to drastic hemodynamic changes, in the setting of uremia, systemic inflammation, oxidative stress and preexistent vascular pathology. AVF can fail due to both failure to mature adequately to support hemodialysis, as well as development of neointimal hyperplasia (NIH) that narrows the AVF lumen, typically near the fistula anastomosis. Failure due to NIH involves vascular cell activation and migration and extracellular matrix remodeling with complex interactions of growth factors, adhesion molecules, inflammatory mediators, and chemokines, all of which result in maladaptive remodeling. Different strategies have been proposed to prevent and treat AVF failure, based on current understanding of the modes and pathology of access failure; these approaches range from appropriate patient selection and use of alternative surgical strategies for fistula creation, to the use of novel interventional techniques or drugs to treat failing fistulae. Effective treatments to prevent or treat AVF failure requires a multidisciplinary approach involving nephrologists, vascular surgeons and interventional radiologists, allowing careful patient selection and the use of tailored systemic or localized interventions to improve patient-specific outcomes. This review provides contemporary information on the underlying mechanisms of AVF maturation and failure and discusses the broad spectrum of options that can be tailored for specific therapy.
登录
查看更多内容
影响因子:
6.7
作者:
Asare, Yaw;Schmitt, Martin;Bernhagen, Juergen
通讯作者:
Bernhagen, Juergen
影响因子:
--
作者:
Aveles, Paulo R.;Criminacio, Ciro R.;Pecoits-Filho, Roberto
通讯作者:
Pecoits-Filho, Roberto
影响因子:
0.9
作者:
Albayrak, Ramazan;Yuksel, Seref;Karaman, Ozcan
通讯作者:
Karaman, Ozcan
DOI:
10.1152/ajprenal.00215.2004
发表时间:
2005-04-01
影响因子:
4.2
作者:
Adin, CA;Croker, BP;Agarwal, A
通讯作者:
Agarwal, A
影响因子:
2.9
作者:
Bhat, Rajesh;McBride, Kieran;Severn, Alison
通讯作者:
Severn, Alison